A recall of chlorpromazine hydrochloride tablets is active nationwide in the United States. A specific lot of packaging material to coils used in manufacturing contained a foreign substance with a microorganism detected. Tablets themselves tested negative for microorganisms. Consumers and healthcare providers should stop using the product immediately and contact Amerisource Health Services LLC or
Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.
Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
Chlorpromazine hydrochloride is an antipsychotic medication used to treat certain psychiatric conditions. It is distributed in blisterpackaged tablets.
A foreign substance in packaging material was detected, with a microorganism present on the packaging coil. No tablets were found contaminated.
This recall is not part of a broader industry pattern.
Consumers may need to stop taking the affected lot and work with healthcare providers to obtain a safe replacement, potential disruption to treatment timelines.
Recall notices and FDA enforcement page D-0647-2025
Refunds/replacements via a letter notification; process timelines vary by distributor
Keep all recall notices, packaging, lot numbers, and correspondence for records
Brand: CHLORPROMAZINE HYDROCHLORIDE. Distributor: American Health Packaging, Columbus, Ohio 43217. Packaging options: a) 50 blisterpacks (5x10) NDC 60687-430-65; Individual Dose NDC 60687-430-11; b) 100 blisterpacks (10x10) NDC 60687-430-01; Individual Dose NDC 60687-430-11. Quantity recalled: 2,708 cartons. Class II recall. Distribution: Nationwide in the USA. Recall date: 2025-08-27.
No injuries or incidents have been reported.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Meclizine Hydrochloride Tablets distributed nationwide by Amerisource Health Services LLC are being recalled. The two affected NDCs are 60687-775-65 and 60687-775-11. The recall is due to failed tablet specifications. Stop using the product and contact a healthcare provider for guidance immediately.
KVK-Tech Inc. recalled 31,676 packages of Oxycodone Hydrochloride Tablets on January 14, 2026. Defective seals may cause tablets to fall out, posing a health risk. Customers should stop using the product immediately and seek guidance from healthcare providers.
27,868 blister packs of Sucralfate Tablets, 1 g, distributed nationwide by American Health Packaging are recalled. The recall stems from CGMP deviations that prevent the firm from assuring product identity, strength, quality and purity. Health providers and consumers should stop using the product immediately and await guidance.
FDA recalls Carbamazepine Extended-Release Tablets, 400 mg, distributed nationwide by American Health Packaging. The recall cites failed dissolution specifications and class II classification. Consumers should stop using and contact healthcare providers for guidance.
American Health Packaging recalled 873 cartons of Chlorpromazine Hydrochloride Tablets, USP, 200 mg, after foreign substances were detected in product packaging. A specific lot of auxiliary polyester coil contained a micro-organism, posing a high health risk. Consumers should stop using the product immediately and contact their healthcare provider for guidance.
A high-severity recall covers chlorpromazine hydrochloride tablets distributed nationwide by American Health Packaging. A foreign substance linked to a polyester coil packaging component was detected at the manufacturing site. No tablets were contaminated. Stop using the product and contact the distributor for guidance.
Chlorpromazine Hydrochloride tablets distributed nationwide by American Health Packaging are recalled after a polyester coil used in packaging showed presence of a micro-organism in a specific lot. No tablets were contaminated. Consumers and healthcare providers should stop using this product immediately and contact Amerisource Health Services LLC for guidance.
AvKare recalls 2,003 cartons of CHLORPROMAZINE HYDROCHLORIDE 100 mg tablets sold nationwide in the United States after a foreign substance was found. The FDA-listed Class II recall is in effect as of 2025-08-25. Stop using the product and contact AvKare or your healthcare provider for guidance.